Regeneron Pharmaceuticals, Inc.

J.W. COLE ADVISORS, INC. REGN

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/23/2026

Shares

855

Value ($000)

661

Weight

0.0%

2020 Q3 - 2026 Q1 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/23/2026	661	0.0%	855	3/31/2026
2025 Q3	11/5/2025	512	0.0%	911	9/30/2025
2025 Q2	8/12/2025	523	0.0%	997	6/30/2025
2025 Q1	5/5/2025	611	0.0%	963	3/31/2025
2024 Q4	1/31/2025	447	0.0%	627	12/31/2024
2024 Q3	10/24/2024	843	0.0%	802	9/30/2024
2024 Q2	8/8/2024	756	0.0%	719	6/30/2024
2024 Q1	4/30/2024	727	0.0%	755	3/31/2024
2023 Q4	1/31/2024	690	0.0%	786	12/31/2023
2023 Q3	10/24/2023	642	0.0%	780	9/30/2023
2023 Q2	7/27/2023	633	0.0%	881	6/30/2023
2023 Q1	5/3/2023	775	0.1%	943	3/31/2023
2022 Q4	2/14/2023	509	0.0%	706	12/31/2022
2022 Q3	10/31/2022	495	0.0%	719	9/30/2022
2022 Q2	7/27/2022	460	0.0%	779	6/30/2022
2022 Q1	6/10/2022	588	0.0%	842	3/31/2022
2021 Q4	1/25/2022	539	0.0%	854	12/31/2021
2021 Q3	10/26/2021	540	0.0%	893	9/30/2021
2021 Q2	8/6/2021	500	0.0%	895	6/30/2021
2021 Q1	4/28/2021	207	0.0%	438	3/31/2021
2020 Q4	2/12/2021	259	0.0%	536	12/31/2020
2020 Q3	11/5/2020	274	0.0%	490	9/30/2020